33 results
10-K
2024 FY
IXHL
Incannex Healthcare Limited
30 Sep 24
Annual report
7:30am
and increased risk of death or injury due to traffic accidents resulting from excessive daytime sleepiness. The substantial patient and society costs
10-K
2024 FY
EX-10.9
IXHL
Incannex Healthcare Limited
30 Sep 24
Annual report
7:30am
by operation of law on death or legal incapacity to the Participant’s legal personal representative.
(w) “Tranche” means a group of Rights defined … the transfer is effected by operation of law on death or legal incapacity to the Participant’s legal personal representative.
10. Measurement Periods
S-1/A
IXHL
Incannex Healthcare Limited
17 Jul 24
IPO registration (amended)
8:47am
concentration and judgment, depression and death or injury due to traffic accidents resulting from excessive daytime sleepiness. The costs associated … activity, or neuroprotection, is defined as reduced neuronal cell death or disruption) in animal studies of TBI and is thought to act by modulating
S-1
IXHL
Incannex Healthcare Limited
3 Jul 24
IPO registration
6:29am
, including cardiovascular disease, cognitive impairments such as memory loss, poor concentration and judgment, depression and death or injury due … death or disruption) in animal studies of TBI and is thought to act by modulating glutamate release and calcium uptake as well as via effects
8-K
EX-99.1
IXHL
Incannex Healthcare Limited
16 Feb 24
Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking Cessation
8:00am
)
Cigarette smoking and nicotine addiction causes a wide variety of preventable diseases and remains a leading cause of preventable death in the United States
8-K
EX-10.2
vir91
29 Nov 23
Entry into a Material Definitive Agreement
4:36pm
8-K
EX-3.1
98i3x3otof1 qa
29 Nov 23
Entry into a Material Definitive Agreement
4:36pm
8-K
EX-3.2
i80v9 x57c5wk
29 Nov 23
Entry into a Material Definitive Agreement
4:36pm
6-K
EX-99.1
f49xbvz4uxwli
25 Nov 22
Incannex Engages Eurofins to Manufacture Novel Addiction Treatments CannQuit-N and CannQuit-O
6:08am
20-F
t4ik54re0x1 g4a
28 Oct 22
Annual report (foreign)
6:31am
6-K
EX-99.1
ayzt91kn
19 Sep 22
Report of Foreign Private Issuer
9:38pm
6-K
EX-99.1
0iejxbek0kero84itd6
9 Aug 22
Report of Foreign Private Issuer
6:01am
6-K
EX-99.3
jjy13f9vhzo5i3szgp
12 May 22
Report of Foreign Private Issuer
9:25am
20FR12B/A
zn6io lg2
24 Feb 22
Initial registration of securities (foreign private issuers) (amended)
3:42pm
20FR12B/A
67bgtu6r0217emq
22 Feb 22
Initial registration of securities (foreign private issuers) (amended)
6:10am
20FR12B
EX-1.1
pieg kfac
24 Jan 22
Initial registration of securities (foreign private issuers)
8:18pm
20FR12B
EX-4.7
ggi0l8e4vjbgjtxyxpu
24 Jan 22
Initial registration of securities (foreign private issuers)
8:18pm
20FR12B
v2tduxby
24 Jan 22
Initial registration of securities (foreign private issuers)
8:18pm